NEVVI Medicare utilization intelligence
or

← back

Provider profile

SMITH, MATTHEW P.A.-C

Physician Assistant · NPI 1295774826 · RANCHO MIRAGE, CA

1
Groups
28
Codes · 2024
11,466
Disclosed services

SMITH, MATTHEW is a Physician Assistant in RANCHO MIRAGE, CA, a member of 1 medical group, who billed 28 distinct codes to Medicare Part B in 2024.

Groups: J ROBERT WEST MD INC (LAS VEGAS, NV)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

11,466
disclosed services
28
codes billed to Medicare Part B
Prior year · CY2023 8,969 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
17000 Destruction of precancer skin growth, 1 growth
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
11102 Biopsy of related skin growth, first growth
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
17004 Destruction of precancer skin growth, 15 or more growths
17110 Destruction of skin growth, 1-14 growths
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11103 Biopsy of related skin growth, each additional growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
11900 Injection into skin growth, 1-7 growths
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
96372 Injection of drug or substance under skin or into muscle
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
69100 Biopsy of ear
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
96405 Administration of chemotherapy into growth, 1-7
J9190 Injection, fluorouracil, 500 mg
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
17111 Destruction of skin growth, 15 or more growths
10060 Simple or single drainage of skin abscess
11200 Removal of skin tag, 1-15 skin tags
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
17263 Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.